[144] Pacira BioSciences, Inc. SEC Filing
Rhea-AI Filing Summary
The issuer submitted a Form 144 notice for the proposed sale of 1,500 shares of Common Stock by Fidelity Brokerage Services LLC, dated 04/22/2026, arising from an option granted on 11/04/2024. The excerpt shows shares outstanding of 40,489,894 as of 04/22/2026. The filing also discloses recent sales by Shawn Cross of 7,714 and 2,845 shares on 04/20/2026 and 04/21/2026, respectively.
Positive
- None.
Negative
- None.
Insights
Form 144 records a proposed sale of restricted/affiliate shares under an option.
The filing lists a proposed disposition of 1,500 shares by Fidelity Brokerage Services LLC tied to an option granted 11/04/2024. Form 144s are notice filings required for certain affiliate sales under Rule 144; they do not themselves effect a sale.
Cash‑flow treatment is stated as Cash and the filing lists shares outstanding of 40,489,894 as of 04/22/2026, providing a size context. Subsequent trade execution and settlement details are not included in the excerpt.
Small proposed block relative to the outstanding float; recent insider disposals are also reported.
The proposed 1,500‑share sale represents a small fraction of the disclosed 40,489,894 shares outstanding as of 04/22/2026. The excerpt also records two recent sales by Shawn Cross totaling 10,559 shares with aggregate proceeds shown.
Execution method is listed as Cash; the timing and whether sales will be block trades or market transactions are not specified in the excerpt.
Key Figures
Key Terms
Form 144 regulatory
Option Granted financial
Aggregate proceeds financial
AI-generated analysis. How Rhea-AI works. Not financial advice.